MF · holdings as filed 2026-03-31

What's inside BBH?

VanEck Biotech ETF

Holdings

positions in the fund

Top 10

71%

of fund assets

Expense ratio

0.35%

net, per year

Fund size

$372M

total net assets

Top 15 holdings

GILDGILEAD SCIENCES INC

14.63%

AMGNAMGEN INC

14.54%

VRTXVERTEX PHARMACEUTICALS INC

8.06%

REGNREGENERON PHARMACEUTICALS

7.51%

ARGXARGENX SE - ADR

5.28%

INSMINSMED INC

4.59%

IQVIQVIA HOLDINGS INC

4.30%

ALNYALNYLAM PHARMACEUTICALS INC

4.11%

NTRANATERA INC

3.98%

UTHRUNITED THERAPEUTICS CORP

3.81%

BIIBBIOGEN INC

3.72%

ONCBEONE MEDICINES LTD-ADR

3.25%

MRNAMODERNA INC

3.10%

RVMDREVOLUTION MEDICINES INC

2.86%

ILMNILLUMINA INC

2.49%

Sectors

1Health Care

90%

2Industrials

3Information Technology

4Unclassified

Geography

1United States

98%

2Ireland

3Netherlands

Hold BBH alongside other funds? See your combined true holdings, overlap, and blended fees — free, no signup.

Unwrap your portfolio →

Data source: official SEC Form N-PORT filings (as of 2026-03-31); expense ratio from SEC prospectus (risk/return) filings. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.